The New Public Health and STD/HIV Prevention

PART 1. Socio-Demographic Societal and Supra-Societal Determinants and Influences.- Chapter 1. Social Determinants of Sexual Networks, Partnership Formation, and Sexually Transmitted Infections.- Chapter 2. Epidemiology of STI and HIV: An Overview of Concentration and Geographical and Temporal Dispersion.- Chapter 3. Migration and the Transmission of STIs.- Chapter 4. Sexual Networks and Sexually Transmitted Infections: "The Strength of Weak (long distance) Ties".- Chapter 5. Personal Risk and Public Impact: Balancing Individual Rights with STD and HIV Prevention.- PART 2. Critical Factors in Approaches to Prevention.- Chapter 6. Distribution of Prevention Resources and Impact on Sexual Health in the United States.- Chapter 7. Scaling-up, Targeting, and Coverage.- Chapter 8. Electronic Media and STI Prevention.- Chapter 9. 21st Century Leadership for Public Health and HIV/STI Prevention.- PART 3. Critical Reviews: New Public Health Focus for Populations at Risk for STI/HIV.- Chapter 10. Enhancing Women's Sexual Health: Prevention Measures in Diverse Populations of Women.- Chapter 11. Prevention of HIV and Other Blood-borne and Sexually Transmitted Diseases in People Who Inject Drugs: Current Status and Future Prospects.- Chapter 12. Health, Sexual Health, and Syndemics: Toward a Better Approach to STI and HIV Preventive Interventions for Men Who Have Sex with Men (MSM) in the United States.- Chapter 13. Social Determinants of Sexual Health in the US among Racial and Ethnic Minorities.- Chapter 14. Adolescent Sexual Health and Sexually Transmitted Infections: A Conceptual and Empirical Demonstration.- PART 4. Critical Reviews: New Public Health STD/HIV Prevention.- Chapter 15. Preventing HIV/AIDS in the United States: History in the Making, 1981-2009: History in the Making.- Chapter 16. A National Strategic Approach to Improving the Health of Gay and

Sevgi O. Aral, MA, MS, PhD, has been the Associate Director for Science in the Division of STD Prevention, Centers for Disease Control since 1993. She holds professorial appointments at the University Of Washington in Seattle; University of Manitoba in Winnipeg and Emory University in Atlanta. Dr. Aral has authored more than 230 scientific articles and edited 16 journal issues and 2 books. Dr. Aral has served on many national and international work groups, boards and committees; and has consulted for the World Health Organization, The European Union and the World Bank. She has received the ASTDA Achievement Award and the Thomas Parran Award. Over the years, her research interests have included social and behavioral aspects of sexually transmitted disease epidemiology and prevention; including gender, age and race effects; mixing patterns; sexual and social networks; contextual factors; social determinants and most recently, program science. Dr. Aral came to the Centers for Disease Control in 1978 from Middle East Technical University in Ankara, Turkey where she was the chair of the Department of Social Sciences.Kevin Fenton, MD, PhD, FFPH, is the Director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC), a position he has held since November 2005. Previously, he was chief of CDC's National Syphilis Elimination Effort and has worked in research, epidemiology, and the prevention of HIV and other STDs since 1995. Before coming to CDC, he was the Director of the HIV and STI Department at the United Kingdom's Health Protection Agency. At CDC, Dr. Fenton has led a number of critical efforts to address the U.S. HIV epidemic, including the release of revised HIV screening recommendations to make HIV testing a routine part of medical care for all Americans, and the implementation of a new surveillance system to provide more precise estimates of new HIV infections in the United States.